Story perspectives

Revolutionary Blood Test Detects HPV Cancers Years Early

9/13/2025

Summary

Story summary

The HPV-DeepSeek blood test can detect HPV-related throat and mouth cancers up to 10 years before symptoms arise, potentially revolutionizing early screening in the U.S.
It employs genome sequencing to find cancer DNA in the bloodstream, showing high accuracy in initial trials.
Early detection could significantly enhance the current 85% five-year survival rate for advanced HPV throat cancers.
A larger study, funded by the National Institutes of Health, is underway to validate these findings.
HPV now represents about 70% of head and neck cancers in the U.S., with increasing cases among younger adults.

1 of 1

Story summary

The HPV-DeepSeek blood test can detect HPV-related throat and mouth cancers up to 10 years before symptoms arise, potentially revolutionizing early screening in the U.S.
It employs genome sequencing to find cancer DNA in the bloodstream, showing high accuracy in initial trials.
Early detection could significantly enhance the current 85% five-year survival rate for advanced HPV throat cancers.
A larger study, funded by the National Institutes of Health, is underway to validate these findings.
HPV now represents about 70% of head and neck cancers in the U.S., with increasing cases among younger adults.